Overview of Platelet Aggregation Devices MarketThe global Platelet Aggregation Devices Market is valued at USD 590.65 Million in 2024 and is projected to reach a value of USD 1086 Million by 2035 at a ...

Foods can change blood-lipid levels, blood pressure, body weight and insulin sensitivity; all the factors that can fluctuate ...

Light responsive nanomotors dissolve blood clots and repair vessel tissue by combining catalytic activity, targeted motion, and gentle heating for coordinated thrombolysis and endothelial regeneration ...

Antiplatelet drug therapy has become one of the cornerstones of treatment for patients with cardiovascular disease. Large clinical trials have shown that antiplatelet medications have important ...

As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive ...

According to the American Heart Association, valvular heart disease affects about 2.5% of adults in the United States, and ...

An engineered CD40 antibody that can bind to a specific immune receptor and directly injected into tumors has demonstrated in a phase 1 trial that it can trigger a systemic immune response.

Oxylipins, particularly arterial 15-keto PGF2a, were identified as significant predictors of 5-year mortality in HFpEF patients. The study utilized high-performance liquid chromatography and mass ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...

Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...